Liu, P.-T.; Chen, Y.-L.; Chen, W.-L.; Ho, C.-L.; Lee, C.-H.
Acquired ROS1 Intragenic Rearrangements as a Resistance Mechanism in EGFR-Mutant Non-Small Cell Lung Cancer: A Case Series. Curr. Oncol. 2026, 33, 311.
https://doi.org/10.3390/curroncol33060311
AMA Style
Liu P-T, Chen Y-L, Chen W-L, Ho C-L, Lee C-H.
Acquired ROS1 Intragenic Rearrangements as a Resistance Mechanism in EGFR-Mutant Non-Small Cell Lung Cancer: A Case Series. Current Oncology. 2026; 33(6):311.
https://doi.org/10.3390/curroncol33060311
Chicago/Turabian Style
Liu, Po-Tsen, Yi-Lin Chen, Wan-Li Chen, Chung-Liang Ho, and Chun-Hui Lee.
2026. "Acquired ROS1 Intragenic Rearrangements as a Resistance Mechanism in EGFR-Mutant Non-Small Cell Lung Cancer: A Case Series" Current Oncology 33, no. 6: 311.
https://doi.org/10.3390/curroncol33060311
APA Style
Liu, P.-T., Chen, Y.-L., Chen, W.-L., Ho, C.-L., & Lee, C.-H.
(2026). Acquired ROS1 Intragenic Rearrangements as a Resistance Mechanism in EGFR-Mutant Non-Small Cell Lung Cancer: A Case Series. Current Oncology, 33(6), 311.
https://doi.org/10.3390/curroncol33060311